Heliyon (May 2024)

Case report and literature review of refractory fungemia caused by Candida vulturna

  • Daichi Setoguchi,
  • Naoki Iwanaga,
  • Yuya Ito,
  • Tatsuro Hirayama,
  • Masataka Yoshida,
  • Kazuaki Takeda,
  • Shotaro Ide,
  • Yohsuke Nagayoshi,
  • Akira Kondo,
  • Masato Tashiro,
  • Takahiro Takazono,
  • Kosuke Kosai,
  • Koichi Izumikawa,
  • Katsunori Yanagihara,
  • Hiroshi Mukae

Journal volume & issue
Vol. 10, no. 10
p. e31464

Abstract

Read online

Candida vulturna is a recently discovered and not widely documented ascomycetous yeast phylogenetically related to the outbreak-causing and multidrug-resistant Candida auris. A middle-aged Japanese man with no discernible immunodeficiency was admitted to hospital with ileal diverticulitis. Following laparoscopic right hemicolectomy against abscess formation on postoperative day (POD) 7, continuous fungemia occurred due to Candida haemulonii, identified using a conventional method by confirming the biochemical phenotype. Micafungin was initiated; however, the fungus was persistently isolated from blood cultures. Eventually, the antifungal agent was changed to a combination of liposomal amphotericin B (L-AMB) and caspofungin (CPFG), which cleared the infection, and no pathogens were detected in the blood cultures on POD 31. Contrast-enhanced computed tomography showed septic emboli in the lungs and spleen; however, no evidence of vasculitis was observed. Moreover, sequential echocardiography did not reveal any signs of infectious endocarditis. Finally, CPFG and L-AMB were administered to the patient for 7 and 9 weeks, respectively, during which the patient's symptoms did not relapse. The strain was later genetically identified as C. vulturna. This case report illustrates a clinical presentation of C. vulturna and provides the diagnostic approach and treatment methods for this pathogen.